首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 3期肝胆胰疾病的内镜诊疗 => 综述 =>经内镜逆行胰胆管造影术后胰腺..
经内镜逆行胰胆管造影术后胰腺炎防治的研究进展
Research advances in the prevention and treatment of pancreatitis after endoscopic retrograde cholangiopancreatography
文章发布日期:2018年02月07日  来源:  作者:张维锋, 李家速, 刘枫,等  点击次数:583次  下载次数:46次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:经内镜逆行胰胆管造影术(ERCP)是目前诊治胆胰疾病的一项重要技术,术后胰腺炎(PEP)是其最常见的并发症。自ERCP诞生以来,PEP防治便成为国际性研究焦点,近年来研究成果层出不穷,在危险因素、药物预防、预防性胰管支架置入等方面取得诸多进展。但研究结论不甚一致,仍需要临床进一步研究证实。
【Abstract】:Endoscopic retrograde cholangiopancreatography (ERCP) is an important technique for the diagnosis and treatment of biliary and pancreatic diseases and post-ERCP pancreatitis (PEP) is the most common complication of ERCP. Since the birth of ERCP, the prevention and treatment of PEP has become the focus of international research. In recent years, much progress has been made in the aspects of risk factors, pharmacological prevention, and prophylactic stent implantation in the pancreatic duct. Since these research findings are not consistent, further clinical studies are needed to demonstrate such findings.
【关键字】:胰腺炎; 胰胆管造影术, 内窥镜逆行; 综述
【Key words】:pancreatitis; cholangiopancreatography, endoscopic retrograde; review
【引证本文】:ZHANG WF, LI JS, LIU F, et al. Research advances in the prevention and treatment of pancreatitis after endoscopic retrograde cholangiopancreatography[J]. J Clin Hepatol, 2018, 34(3): 658-662. (in Chinese)
张维锋, 李家速, 刘枫, 等. 经内镜逆行胰胆管造影术后胰腺炎防治的研究进展[J]. 临床肝胆病杂志, 2018, 34(3): 658-662. (本文编辑:刘晓红)

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号